The Innovative Medicines Initiative (IMI) 10th Call for Proposal launched and will be managed in two stage.
The submission system will close for stage 1 proposals under this Call on 28 March 2017.
To submit a proposal via the electronic submission system, applicants will need to have H2020 Participant Portal account.
The size and composition of each consortium should be adapted so as to respond to the scientific goals and the expected key deliverables.
For detailed information about the call: http://www.imi.europa.eu/content/imi-2-call-10
Call topics
Topic 1: Understanding hypoglycaemia: the underlying mechanisms and addressing clinical determinants as well as consequences for people with diabetes by combining databases from clinical trials
Topic 2: How big data could support better diagnosis and treatment outcomes for prostate cancer (part of the Big Data for Better Outcomes programme)
Topic 3: Improving the care of patients suffering from acute or chronic pain (this topic includes three subtopics on patient reported outcomes; biomarkers; and chronic pelvic pain)
Topic 4: Creation of a pan-European paediatric clinical trials network
Topic 5: Biomanufacturing 2020: development of innovative high throughput analytical tools and methods to characterize cell culture fluid during development and commercial cell culture processes
Topic 6: Unlocking the solute carrier gene-family for effective new therapies (unlock SLCs)
Topic 7: Patient perspectives in medicines lifecycle
Topic 8: Personalised medicine approaches in autism spectrum disorders